Pfizer (PFE) reported Q2 FY 2021 earnings of $1.07 per share (versus $0.78 per share in Q2 FY 2020), beating analysts’ consensus estimate of $0.98 per share.
The company’s quarterly revenues amounted to $18.977 bln (+60.8% y/y), beating analysts’ consensus estimate of $18.725 bln.
PFE rose to $42.14 (+0.10%) in pre-market trading.